Stay updated on UCART123v1.2 in AML Relapse/Refractory - Clinical Trial

Sign up to get notified when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-22T21:24:54.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    1%
    Check dated 2025-05-01T05:46:26.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2025-04-23T22:32:23.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has undergone significant changes regarding the study of UCART123 for relapsed/refractory acute myeloid leukemia, with the removal of detailed study descriptions and inclusion/exclusion criteria, while a new version number has been added.
    Difference
    14%
    Check dated 2025-04-16T14:44:34.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.5%
    Check dated 2025-04-09T10:20:26.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:41:02.000Z thumbnail image

Stay in the know with updates to UCART123v1.2 in AML Relapse/Refractory - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.